The first successful cochlear implant in Latin America after severe aminoglycosideinduced ot otoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis

Samuel Pecho-Silva; Ana Claudia Navarro-Solsol; Vicky Panduro-Correa; Jorge L. Maguina; Ali A. Rabaan; Luis Rene Quiroz-Ramirez; Kovy Arteaga-Livias; Alfonso J. Rodriguez-Morales

doi:10.35434/rcmhnaaa.2022.154.1501

The first successful cochlear implant in Latin America after severe aminoglycosideinduced ot otoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis

Samuel Pecho-Silva, Ana Claudia Navarro-Solsol, Vicky Panduro-Correa, Jorge L. Maguina, Ali A. Rabaan, Luis Rene Quiroz-Ramirez, Kovy Arteaga-Livias, Alfonso J. Rodriguez-Morales

Medicina humana

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Multidrug-resistant tuberculosis is a significant public health problem for which drugs are used with many adverse effects. Among the devastating consequences of these diseases, there is a wide variation in the incidence of ototoxicity and hearing loss in patients with multidrug-resistant and extremely resistant tuberculosis. Cochlear implants may be indicated in patients with unilateral/severe bilateral hearing loss with no benefit from conventional hearing aids, but their use in patients with tuberculosis is rare. Case report: We present the first case of a right unilateral cochlear implant performed on a 34-year-old Peruvian patient who presented profound sensorineural hearing loss of cochlear origin. Conclusion: Cochlear implant surgery is an essential milestone in the treatment of patients with auditory sequelae of tuberculosis treatment. Close monitoring of possible complications of tuberculosis treatment should be strengthened in countries with a high incidence of multidrug-resistant and extremely resistant tuberculosis.

Translated title of the contribution	Primer implante coclear exitoso en América Latina después de ototoxicidad severa inducida por aminoglucósidos en un paciente peruano curado de una tuberculosis extremadamente resistente
Original language	English
Pages (from-to)	622-625
Number of pages	4
Journal	Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
Volume	15
Issue number	4
DOIs	https://doi.org/10.35434/rcmhnaaa.2022.154.1501
State	Published - Oct 2022

Keywords

Hearing loss
Latin Americax (Source: DeCS-BIREME)
Tuberculosis
extensively drug-resistant tuberculosis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.35434/rcmhnaaa.2022.154.1501

Cite this

Pecho-Silva, S., Navarro-Solsol, A. C., Panduro-Correa, V., Maguina, J. L., Rabaan, A. A., Quiroz-Ramirez, L. R., Arteaga-Livias, K., & Rodriguez-Morales, A. J. (2022). The first successful cochlear implant in Latin America after severe aminoglycosideinduced ot otoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis. Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo, 15(4), 622-625. https://doi.org/10.35434/rcmhnaaa.2022.154.1501

@article{e9ccf67575df467e8362adf7fee2b741,

title = "The first successful cochlear implant in Latin America after severe aminoglycosideinduced ot otoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis",

abstract = "Background: Multidrug-resistant tuberculosis is a significant public health problem for which drugs are used with many adverse effects. Among the devastating consequences of these diseases, there is a wide variation in the incidence of ototoxicity and hearing loss in patients with multidrug-resistant and extremely resistant tuberculosis. Cochlear implants may be indicated in patients with unilateral/severe bilateral hearing loss with no benefit from conventional hearing aids, but their use in patients with tuberculosis is rare. Case report: We present the first case of a right unilateral cochlear implant performed on a 34-year-old Peruvian patient who presented profound sensorineural hearing loss of cochlear origin. Conclusion: Cochlear implant surgery is an essential milestone in the treatment of patients with auditory sequelae of tuberculosis treatment. Close monitoring of possible complications of tuberculosis treatment should be strengthened in countries with a high incidence of multidrug-resistant and extremely resistant tuberculosis.",

keywords = "Hearing loss, Latin Americax (Source: DeCS-BIREME), Tuberculosis, extensively drug-resistant tuberculosis",

author = "Samuel Pecho-Silva and Navarro-Solsol, {Ana Claudia} and Vicky Panduro-Correa and Maguina, {Jorge L.} and Rabaan, {Ali A.} and Quiroz-Ramirez, {Luis Rene} and Kovy Arteaga-Livias and Rodriguez-Morales, {Alfonso J.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = oct,

doi = "10.35434/rcmhnaaa.2022.154.1501",

language = "Ingl{\'e}s",

volume = "15",

pages = "622--625",

journal = "Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo",

issn = "2225-5109",

publisher = "Cuerpi Medico del Hospital Nacional Almanzor Aguinaga Asenjo (HNAAA)",

number = "4",

}

Pecho-Silva, S, Navarro-Solsol, AC, Panduro-Correa, V, Maguina, JL, Rabaan, AA, Quiroz-Ramirez, LR, Arteaga-Livias, K & Rodriguez-Morales, AJ 2022, 'The first successful cochlear implant in Latin America after severe aminoglycosideinduced ot otoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis', Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo, vol. 15, no. 4, pp. 622-625. https://doi.org/10.35434/rcmhnaaa.2022.154.1501

The first successful cochlear implant in Latin America after severe aminoglycosideinduced ot otoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis. / Pecho-Silva, Samuel; Navarro-Solsol, Ana Claudia; Panduro-Correa, Vicky et al.
In: Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo, Vol. 15, No. 4, 10.2022, p. 622-625.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The first successful cochlear implant in Latin America after severe aminoglycosideinduced ot otoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis

AU - Pecho-Silva, Samuel

AU - Navarro-Solsol, Ana Claudia

AU - Panduro-Correa, Vicky

AU - Maguina, Jorge L.

AU - Rabaan, Ali A.

AU - Quiroz-Ramirez, Luis Rene

AU - Arteaga-Livias, Kovy

AU - Rodriguez-Morales, Alfonso J.

N1 - Publisher Copyright: © The Author(s) 2022.

PY - 2022/10

Y1 - 2022/10

N2 - Background: Multidrug-resistant tuberculosis is a significant public health problem for which drugs are used with many adverse effects. Among the devastating consequences of these diseases, there is a wide variation in the incidence of ototoxicity and hearing loss in patients with multidrug-resistant and extremely resistant tuberculosis. Cochlear implants may be indicated in patients with unilateral/severe bilateral hearing loss with no benefit from conventional hearing aids, but their use in patients with tuberculosis is rare. Case report: We present the first case of a right unilateral cochlear implant performed on a 34-year-old Peruvian patient who presented profound sensorineural hearing loss of cochlear origin. Conclusion: Cochlear implant surgery is an essential milestone in the treatment of patients with auditory sequelae of tuberculosis treatment. Close monitoring of possible complications of tuberculosis treatment should be strengthened in countries with a high incidence of multidrug-resistant and extremely resistant tuberculosis.

AB - Background: Multidrug-resistant tuberculosis is a significant public health problem for which drugs are used with many adverse effects. Among the devastating consequences of these diseases, there is a wide variation in the incidence of ototoxicity and hearing loss in patients with multidrug-resistant and extremely resistant tuberculosis. Cochlear implants may be indicated in patients with unilateral/severe bilateral hearing loss with no benefit from conventional hearing aids, but their use in patients with tuberculosis is rare. Case report: We present the first case of a right unilateral cochlear implant performed on a 34-year-old Peruvian patient who presented profound sensorineural hearing loss of cochlear origin. Conclusion: Cochlear implant surgery is an essential milestone in the treatment of patients with auditory sequelae of tuberculosis treatment. Close monitoring of possible complications of tuberculosis treatment should be strengthened in countries with a high incidence of multidrug-resistant and extremely resistant tuberculosis.

KW - Hearing loss

KW - Latin Americax (Source: DeCS-BIREME)

KW - Tuberculosis

KW - extensively drug-resistant tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=85165287785&partnerID=8YFLogxK

U2 - 10.35434/rcmhnaaa.2022.154.1501

DO - 10.35434/rcmhnaaa.2022.154.1501

M3 - Artículo

AN - SCOPUS:85165287785

SN - 2225-5109

VL - 15

SP - 622

EP - 625

JO - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo

JF - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo

IS - 4

ER -

Pecho-Silva S, Navarro-Solsol AC, Panduro-Correa V, Maguina JL, Rabaan AA, Quiroz-Ramirez LR et al. The first successful cochlear implant in Latin America after severe aminoglycosideinduced ot otoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis. Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo. 2022 Oct;15(4):622-625. doi: 10.35434/rcmhnaaa.2022.154.1501

The first successful cochlear implant in Latin America after severe aminoglycosideinduced ot otoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this